Related references
Note: Only part of the references are listed.Mass Spectrometry Analysis of Newly Emerging Coronavirus HCoV-19 Spike Protein and Human ACE2 Reveals Camouflaging Glycans and Unique Post-Translational Modifications
Zeyu Sun et al.
ENGINEERING (2021)
Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2
Zhixin Liu et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies
Ying Huang et al.
JOURNAL OF VIROLOGY (2020)
An interactive web-based dashboard to track COVID-19 in real time
Ensheng Dong et al.
LANCET INFECTIOUS DISEASES (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
Syed Faraz Ahmed et al.
VIRUSES-BASEL (2020)
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Michael Letko et al.
NATURE MICROBIOLOGY (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
Updated Approaches against SARS-CoV-2
Haiou Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furinlike cleavage site absent in CoV of the same clade
B. Coutard et al.
ANTIVIRAL RESEARCH (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States
Joseph R. Fauver et al.
CELL (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Vanessa Monteil et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Shuai Xia et al.
CELL RESEARCH (2020)
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
Wanbo Tai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
Ning Wang et al.
FRONTIERS IN MICROBIOLOGY (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Site-specific glycan analysis of the SARS-CoV-2 spike
Yasunori Watanabe et al.
SCIENCE (2020)
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
Meng Yuan et al.
SCIENCE (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop
Javier A. Jaimes et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Shibo Jiang et al.
TRENDS IN IMMUNOLOGY (2020)
A human monoclonal antibody blocking SARS-CoV-2 infection
Chunyan Wang et al.
NATURE COMMUNICATIONS (2020)
Immunogenicity of a DNA vaccine candidate for COVID-19
Trevor R. F. Smith et al.
NATURE COMMUNICATIONS (2020)
Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
Yasunori Watanabe et al.
NATURE COMMUNICATIONS (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
Changhai Lei et al.
NATURE COMMUNICATIONS (2020)
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
Yanwen Liang et al.
FRONTIERS IN IMMUNOLOGY (2020)
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development
Cuiqing Ma et al.
MICROBES AND INFECTION (2020)
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
Markus Hoffmann et al.
MOLECULAR CELL (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Structural basis of receptor recognition by SARS-CoV-2
Jian Shang et al.
NATURE (2020)
The proximal origin of SARS-CoV-2
Kristian G. Andersen et al.
NATURE MEDICINE (2020)
The COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Developing Covid-19 Vaccines at Pandemic Speed
Nicole Lurie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Progress and Prospects on Vaccine Development against SARS-CoV-2
Jinyong Zhang et al.
VACCINES (2020)
Coronavirus membrane fusion mechanism offers a potential target for antiviral development
Tiffany Tang et al.
ANTIVIRAL RESEARCH (2020)
Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear
Nathan D. Grubaugh et al.
CELL (2020)
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Qianqian Li et al.
CELL (2020)
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
Lianpan Dai et al.
CELL (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition
M. Eugenia Dieterle et al.
CELL HOST & MICROBE (2020)
Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
Ren Yang et al.
EBIOMEDICINE (2020)
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
Lakshmanane Premkumar et al.
SCIENCE IMMUNOLOGY (2020)
Vaccines against Coronaviruses: The State of the Art
Cristiano Conte et al.
VACCINES (2020)
COVID-19: Emergence, Spread, Possible Treatments, and Global Burden
Raghuvir Keni et al.
FRONTIERS IN PUBLIC HEALTH (2020)
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Fabian Schmidt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
Dorothea Bestle et al.
LIFE SCIENCE ALLIANCE (2020)
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
Jingyun Yang et al.
NATURE (2020)
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Kizzmekia S. Corbett et al.
NATURE (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu et al.
NATURE (2020)
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Ann M. Arvin et al.
NATURE (2020)
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi et al.
SCIENCE (2020)
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum et al.
SCIENCE (2020)
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
Ching-Lin Hsieh et al.
SCIENCE (2020)
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna Hansen et al.
SCIENCE (2020)
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
Zhe Lv et al.
SCIENCE (2020)
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer et al.
SCIENCE (2020)
Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits
Supriya Ravichandran et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses (vol 41, pg 355, 2020)
Shibo Jiang et al.
TRENDS IN IMMUNOLOGY (2020)
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
Huibin Lv et al.
CELL REPORTS (2020)
In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges
Beata Turonova et al.
SCIENCE (2020)
Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19
Kumaragurubaran Karthik et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
The SARS-CoV-2 Vaccine Pipeline: an Overview
Wen-Hsiang Chen et al.
CURRENT TROPICAL MEDICINE REPORTS (2020)
Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2
Danielle E. Anderson et al.
EMERGING MICROBES & INFECTIONS (2020)
Structure-Based Vaccine Antigen Design
Barney S. Graham et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
Alexandra C. Walls et al.
CELL (2019)
Protein and Glycan Mimicry in HIV Vaccine Design
Gemma E. Seabright et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Structural Vaccinology for Viral Vaccine Design
Mohd Ishtiaq Anasir et al.
FRONTIERS IN MICROBIOLOGY (2019)
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
Shuai Xia et al.
SCIENCE ADVANCES (2019)
Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
Chean Yeah Yong et al.
FRONTIERS IN MICROBIOLOGY (2019)
Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability
Viktoriya Dubrovskaya et al.
IMMUNITY (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Antibodies and vaccines against Middle East respiratory syndrome coronavirus
Jiuyang Xu et al.
EMERGING MICROBES & INFECTIONS (2019)
SnapShot: O-Glycosylation Pathways across Kingdoms
Hiren J. Joshi et al.
CELL (2018)
Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines
Felix A. Rey et al.
CELL (2018)
Structure of the Lassa virus glycan shield provides a model for immunological resistance
Yasunori Watanabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Structure and Immune Recognition of the HIV Glycan Shield
Max Crispin et al.
ANNUAL REVIEW OF BIOPHYSICS, VOL 47 (2018)
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Jesper Pallesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
What Are the Most Powerful Immunogen Design Vaccine Strategies?
Peter D. Kwong
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise
Dennis R. Burton
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
Yuan Yuan et al.
NATURE COMMUNICATIONS (2017)
T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
William J. Liu et al.
ANTIVIRAL RESEARCH (2017)
l Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G
Guillaume B. E. Stewart-Jones et al.
CELL (2016)
The contribution of the cytoplasmic retrieval signal of severe acute respiratory syndrome coronavirus to intracellular accumulation of S proteins and incorporation of S protein into virus-like particles
Makoto Ujike et al.
JOURNAL OF GENERAL VIROLOGY (2016)
Glycosylation Quality Control by the Golgi Structure
Xiaoyan Zhang et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer
Alexandra C. Walls et al.
NATURE (2016)
Pre-fusion structure of a human coronavirus spike protein
Robert N. Kirchdoerfer et al.
NATURE (2016)
Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy
Alexandra C. Walls et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy
Alexandra C. Walls et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Insights into vaccine development for acquired immune deficiency syndrome from crystal structures of human immunodeficiency virus-1 gp41 and equine infectious anemia virus gp45
Liangwei Duan et al.
PROTEIN SCIENCE (2015)
Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1
George K. Lewis et al.
VIRUSES-BASEL (2015)
Evaluation of candidate vaccine approaches for MERS-CoV
Lingshu Wang et al.
NATURE COMMUNICATIONS (2015)
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
Max Crispin et al.
CURRENT OPINION IN VIROLOGY (2015)
Proof of principle for epitope-focused vaccine design
Bruno E. Correia et al.
NATURE (2014)
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
Marie Pancera et al.
NATURE (2014)
Recent strategies targeting HIV glycans in vaccine design
Satoru Horiya et al.
NATURE CHEMICAL BIOLOGY (2014)
Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions
James B. Munro et al.
SCIENCE (2014)
Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus
Marion Sevajol et al.
VIRUS RESEARCH (2014)
N-linked protein glycosylation in the ER
Markus Aebi
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Guangwen Lu et al.
NATURE (2013)
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
Jason S. McLellan et al.
SCIENCE (2013)
Protein Folding in the Endoplasmic Reticulum
Ineke Braakman et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
N-Linked Protein Glycosylation in the Endoplasmic Reticulum
Joerg Breitling et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome
Shibo Jiang et al.
EXPERT REVIEW OF VACCINES (2012)
Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
Sandrine Belouzard et al.
VIRUSES-BASEL (2012)
Mechanisms and principles of N-linked protein glycosylation
Flavio Schwarz et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2011)
Quasispecies Theory and the Behavior of RNA Viruses
Adam S. Lauring et al.
PLOS PATHOGENS (2010)
The spike protein of SARS-CoV - a target for vaccine and therapeutic development
Lanying Du et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Viral membrane fusion
Stephen C. Harrison
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
The intracellular sites of early replication and budding of SARS-coronavirus
Silke Stertz et al.
VIROLOGY (2007)
The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein
Corrin E. McBride et al.
JOURNAL OF VIROLOGY (2007)
Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody
Ponraj Prabakaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry
R Broer et al.
JOURNAL OF VIROLOGY (2006)
High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: a novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins
WL Liu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2
SK Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site
E Lontok et al.
JOURNAL OF VIROLOGY (2004)
The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex
BJ Bosch et al.
JOURNAL OF VIROLOGY (2003)
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
PD Kwong et al.
NATURE (2002)
Intracellular functions of N-linked glycans
A Helenius et al.
SCIENCE (2001)
Share Paper
